Bearish Options Activity in HP, Inc. (HPQ) Targets Downside in Shares Following Weak Earnings Report This Week -Susquehanna

Go back to Bearish Options Activity in HP, Inc. (HPQ) Targets Downside in Shares Following Weak Earnings Report This Week -Susquehanna

HP, Inc. (HPQ) PT Lowered to $25 at Citi

February 28, 2019 7:49 AM EST

Citi analyst Jim Suva lowered the price target on HP, Inc. (NYSE: HPQ) to $25.00 (from $27.00) while maintaining a Buy rating.

... More

HP, Inc. (HPQ) PT Cut At Susquehanna On Weaker Printing Supplies Business

February 28, 2019 7:42 AM EST

Susquehanna analyst, David Ryzhik, reiterated his Neutral rating on shares of HP, Inc. (NYSE: HPQ) cutting his price target to $23 after the company reported January-quarter headline results and offered an April-quarter EPS guide that were relatively in-line with expectations. The problem comes with... More

HP, Inc. (HPQ) PT Lowered to $20 at BMO Capital

February 28, 2019 7:34 AM EST

BMO Capital analyst Tim Long lowered the price target on HP, Inc. (NYSE: HPQ) to $20.00 (from $22.00) while maintaining a Market Perform rating.

... More

HP, Inc. (HPQ) PT Lowered to $23 at Wells Fargo

February 28, 2019 7:20 AM EST

Wells Fargo analyst Aaron Rakers lowered the price target on HP, Inc. (NYSE: HPQ) to $23.00 (from $26.00) while maintaining a Market Perform rating.

... More

BofA/Merrill Lynch Downgrades HP, Inc. (HPQ) to Underperform

February 28, 2019 6:10 AM EST

BofA/Merrill Lynch downgraded HP, Inc. (NYSE: HPQ) from Buy to Underperform with a price target of $19.00.

The analyst offers the following reasons for the downgrade:

Too much volatility in supplies growth,a high guidance bar,omni-channel... More

After-Hours Movers 02/27: (TTOO) (TWNK) (WBC) Higher; (BOX) (BKNG) (CELG) (more...)

February 27, 2019 5:33 PM EST

Today's After-Hours Movers

T2 Biosystems, Inc. (NASDAQ: TTOO) 31.7% HIGHER; The FDA has granted T2 Biosystems, Inc. (NASDAQ: TTOO) Breakthrough Device designation for the T2Resistance Panel, a diagnostic panel that can detect 13 resistance genes from both gram-positive and gram-negative pathogens from a single patient blood sample, without the wait for blood culture.

Box (NYSE: BOX) 23.6% LOWER; reported Q4 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $163.7... More

HP, Inc. (HPQ) Reports In-Line Q1 EPS, Offers Q2 and FY Guidance

February 27, 2019 4:15 PM EST

HP, Inc. (NYSE: HPQ) reported Q1 EPS of $0.52, in-line with the analyst estimate of $0.52. Revenue for the quarter came in at $14.7 billion versus the consensus estimate of $14.88 billion.

GUIDANCE:

HP, Inc. sees FY2019 EPS of $2.12-$2.22, versus the consensus... More